PHAGEPRO

phagepro-logo

PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world's most vulnerable communities.

#SimilarOrganizations #People #Financial #Website #More

PHAGEPRO

Social Links:

Industry:
Biotechnology

Address:
Boston, Massachusetts, United States

Country:
United States

Website Url:
http://www.phageproinc.com

Total Employee:
1+

Status:
Active

Email Addresses:
[email protected]

Total Funding:
3.09 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Content Delivery Network Euro Typekit Squarespace Squarespace Add To Cart


Similar Organizations

calimmune-logo

Calimmune

Calimmune is a clinical-stage gene therapy company.

context-therapeutics-logo

Context Therapeutics

Context Therapeutics is a clinical-stage biopharmaceutical company.

Current Employees Featured

andrew-camilli_image

Andrew Camilli
Andrew Camilli Co-Founder & Scientific Advisor @ PhagePro
Co-Founder & Scientific Advisor

minimin-yen_image

Minimin Yen
Minimin Yen Co-Founder & Chief Executive Officer @ PhagePro
Co-Founder & Chief Executive Officer

Founder


andrew-camilli_image

Andrew Camilli

minimin-yen_image

Minimin Yen

Investors List

national-institutes-of-health_image

National Institutes of Health

National Institutes of Health investment in Grant - PhagePro

massachusetts-life-sciences-center_image

Massachusetts Life Sciences Center

Massachusetts Life Sciences Center investment in Grant - PhagePro

Official Site Inspections

http://www.phageproinc.com

  • Host name: a0b1d980e1f2226c6.awsglobalaccelerator.com
  • IP address: 52.223.52.2
  • Location: Seattle United States
  • Latitude: 47.6348
  • Longitude: -122.3451
  • Metro Code: 819
  • Timezone: America/Los_Angeles
  • Postal: 98109

Loading ...

More informations about "PhagePro"

PhagePro

PhagePro is a team of phage and bacteria experts committed to bringing together experts in public policy, industry, and commercialization with leaders and stakeholders on the ground committed to innovation in communities that need โ€ฆSee details»

Who We Are | ProPhage - phageproinc.com

PhagePro strives to build a company grounded in diversity and inclusion. Interwoven into all levels of the company are efforts to provide more leadership opportunities to women and people of color.See details»

PhagePro - Crunchbase Company Profile & Funding

Contact Email [email protected] PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world's most vulnerable โ€ฆSee details»

PhagePro - LinkedIn

PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the worldโ€™s most vulnerable communities.See details»

PHAGEPRO, INC. Company Profile | Boston, MA - Dun & Bradstreet

Find company research, competitor information, contact details & financial data for PHAGEPRO, INC. of Boston, MA. Get the latest business insights from Dun & Bradstreet.See details»

Company Information - RocketReach

PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the worldโ€™s most vulnerable communities.See details»

PhagePro Company Profile 2024: Valuation, Funding & Investors

PhagePro General Information Description. Developer of bacteriophage-based products designed to prevent bacterial infections in global health. The company's products provide an alternative โ€ฆSee details»

PhagePro

May 21, 2021 PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the worldโ€™s most vulnerable communities.See details»

PhagePro - Overview, News & Similar companies | ZoomInfo.com

View PhagePro (www.phageproinc.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well as employees by title and โ€ฆSee details»

PhagePro - VentureRadar

"PhagePro, PBC is a biotech startup focused on developing phage-based solutions to combat antimicrobial resistance in emerging markets. The company emphasizes innovative science โ€ฆSee details»

PhagePro Overview | SignalHire Company Profile

PhagePro is an early-stage biotechnology therapeutics company that develops bacteriophage-based products to help the world's most vulnerable communities.See details»

PhagePro Company Profile - Craft

PhagePro is is an early-stage biotechnology therapeutics company that develops bacteriophage-based products. It offers ProphaLytic-VC, an orally dosed preparation of bacteriophage that is โ€ฆSee details»

PhagePro - Products, Competitors, Financials, Employees, โ€ฆ

PhagePro is an early-stage biotechnology company focused on developing bacteriophage-based therapeutics. Use the CB Insights Platform to explore PhagePro's full profile.See details»

Contact | ProPhage - phageproinc.com

Have questions or comments? You can contact us here.See details»

PhagePro - Work in biotech

PhagePro is developing phage treatments to solve the globeโ€™s largest health disparities and antibiotic resistance. As bacteria build resistance to antibiotics, alternative killing methods are โ€ฆSee details»

Phagepro, Inc. in Boston, MA - (571) 215-4863 - Company Profile

Phagepro, Inc. is in the Biotechnical Research, Commercial business. View competitors, revenue, employees, website and phone number.See details»

PhagePro, Inc. - Drug pipelines, Patents, Clinical trials - Synapse

Explore PhagePro, Inc. with its drug pipeline, therapeutic area, technology platform, , Drug:ProphaLytic-VC.See details»

Bacteriophage formulation for prevention of cholera infection โ€ฆ

A venture spun out of Tufts University School of Medicine www.phageproinc.com Technology Formulation of three bacteriophages that replicate inside cholera bacteria and cause โ€ฆSee details»

Power of Phages | PhagePro

Bacteriophages, or phages, are natural predators of bacteria. They are abundant everywhere - on land, in water, even within the human body. Since they only target bacteria, they are safe and โ€ฆSee details»

Phages: A potential new solution to defeat antimicrobial resistance

Jan 21, 2022 It was reported that approximately 700,000 people around the world die of resistant infections every year, due to antimicrobial drugs becoming less effective at killing resistant โ€ฆSee details»

linkstock.net © 2022. All rights reserved